AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/163
HEME INDUCES ENDOTHELIAL-CELL ACTIVATION AND LEUKOCYTE BINDING
Authors: WAGENER FADTG DEWITTE T ABRAHAM NG
Citation: Fadtg. Wagener et al., HEME INDUCES ENDOTHELIAL-CELL ACTIVATION AND LEUKOCYTE BINDING, The FASEB journal, 12(5), 1998, pp. 5644-5644
APPARENT EXPANSION OF CD34(-LEUKEMIA() CELLS DURING THE EVOLUTION OF MYELODYSPLASTIC SYNDROMES TO ACUTE MYELOID)
Authors: SPAN LFR DAR SE SHETTY V MUNDLE SD BROADYROBINSON L ALVI S RAYMAKERS RAP DEWITTE T RAZA A
Citation: Lfr. Span et al., APPARENT EXPANSION OF CD34(-LEUKEMIA() CELLS DURING THE EVOLUTION OF MYELODYSPLASTIC SYNDROMES TO ACUTE MYELOID), Leukemia, 12(11), 1998, pp. 1685-1695
IN AML T(8-21) COLONY GROWTH OF BOTH LEUKEMIC AND RESIDUAL NORMAL PROGENITORS IS RESTRICTED TO THE CD34(-NEGATIVE FRACTION() LINEAGE)
Authors: WITTEBOL S RAYMAKERS R VANDELOCHT L MENSINK E DEWITTE T
Citation: S. Wittebol et al., IN AML T(8-21) COLONY GROWTH OF BOTH LEUKEMIC AND RESIDUAL NORMAL PROGENITORS IS RESTRICTED TO THE CD34(-NEGATIVE FRACTION() LINEAGE), Leukemia, 12(11), 1998, pp. 1782-1788
IDARUBICIN TO INTENSIFY THE CONDITIONING REGIMENS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: JERJIS S ROOVERS E MUUS P SCHAAP N DEWITTE T
Citation: S. Jerjis et al., IDARUBICIN TO INTENSIFY THE CONDITIONING REGIMENS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION, Bone marrow transplantation, 22(1), 1998, pp. 13-19
BONE-MARROW TRANSPLANTATION FROM HLA IDENTICAL SIBLINGS AS FIRST-LINETREATMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - EARLY TRANSPLANTATION IS ASSOCIATED WITH IMPROVED OUTCOME
Authors: RUNDE V DEWITTE T ARNOLD R GRATWOHL A HERMANS J VANBIEZEN A NIEDERWIESER D LABOPIN M WALTERNOEL MP BACIGALUPO A JACOBSEN N LJUNGMAN P CARRERAS E KOLB HJ AUL C APPERLEY J
Citation: V. Runde et al., BONE-MARROW TRANSPLANTATION FROM HLA IDENTICAL SIBLINGS AS FIRST-LINETREATMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - EARLY TRANSPLANTATION IS ASSOCIATED WITH IMPROVED OUTCOME, Bone marrow transplantation, 21(3), 1998, pp. 255-261
THE USE OF COUNTERFLOW CENTRIFUGATION ELUTRIATION (CCE) TO DEPLETE T-CELLS FROM ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL GRAFTS
Authors: PREIJERS F SCHATTENBERG A RUIJS P DEWITTE T
Citation: F. Preijers et al., THE USE OF COUNTERFLOW CENTRIFUGATION ELUTRIATION (CCE) TO DEPLETE T-CELLS FROM ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL GRAFTS, Bone marrow transplantation, 21, 1998, pp. 27-27
UNRELATED BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND SECONDARY ACUTE MYELOID-LEUKEMIA - AN EBMT SURVEY
Authors: ARNOLD R DEWITTE T VANBIEZEN A HERMANS J JACOBSEN N RUNDE V GRATWOHL A APPERLEY JF
Citation: R. Arnold et al., UNRELATED BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND SECONDARY ACUTE MYELOID-LEUKEMIA - AN EBMT SURVEY, Bone marrow transplantation, 21(12), 1998, pp. 1213-1216
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA
Authors: DEWITTE T VANBIEZEN A HERMANS J SUCIU S DARDENNE M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A MELONI G MAURI SB CARELLA A LAPORTE J DEMUYNCK H NIEDERWIESER D GRATWOHL A APPERLEY J
Citation: T. Dewitte et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 37-37
RESULTS OF POSTCONSOLIDATION TREATMENT FOR PATIENTS LESS-THAN 51 YEARS OF AGE WITH AML IN FIRST CR IN THE AML 10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP OF THE EORTC AND GIMEMA
Authors: KEATING S SUCIU S MANDELLI F DEWITTE T ZITTOUN R ARCHIMBAUD E RESEGOTTI L MELONI G FAZI P DARDENNE M WILLEMZE R
Citation: S. Keating et al., RESULTS OF POSTCONSOLIDATION TREATMENT FOR PATIENTS LESS-THAN 51 YEARS OF AGE WITH AML IN FIRST CR IN THE AML 10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP OF THE EORTC AND GIMEMA, Bone marrow transplantation, 21, 1998, pp. 44-44
ENHANCED INCIDENCE OF CHRONIC GVHD AND REDUCED RELAPSE RATE FOLLOWINGT-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS COMPARED TO T-CELL DEPLETED BONE-MARROW TRANSPLANTATION
Authors: CORNELISSEN JJ LOWENBERG B FIBBE W WILLEMZE R SCHATTENBERG A DEWITTE T PETERSEN E VERDONCK LF VANBIEZEN A BRAND R
Citation: Jj. Cornelissen et al., ENHANCED INCIDENCE OF CHRONIC GVHD AND REDUCED RELAPSE RATE FOLLOWINGT-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS COMPARED TO T-CELL DEPLETED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 48-48
COMPARISON OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION WITH GRAFTSDEPLETED OF LYMPHOCYTES USING COUNTERFLOW CENTRIFUGATION
Authors: SCHATTENBERG A PREIJERS F SCHAAP N DEWITTE T
Citation: A. Schattenberg et al., COMPARISON OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION WITH GRAFTSDEPLETED OF LYMPHOCYTES USING COUNTERFLOW CENTRIFUGATION, Bone marrow transplantation, 21, 1998, pp. 141-141
SEQUENTIAL-ANALYSIS OF CHIMERISM USING RED-BLOOD-CELL PHENOTYPING IS STRONGLY CORRELATED WITH HEMATOLOGIC, CYTOGENETIC AND QUANTITATIVE MOLECULAR RESPONSE AFTER DONOR LEUKOCYTE INFUSIONS FOR RELAPSED CHRONIC MYELOID-LEUKEMIA
Authors: SCHAAP N SCHATTENBERG A BAR B MENSINK E DEMAN A DEWITTE T
Citation: N. Schaap et al., SEQUENTIAL-ANALYSIS OF CHIMERISM USING RED-BLOOD-CELL PHENOTYPING IS STRONGLY CORRELATED WITH HEMATOLOGIC, CYTOGENETIC AND QUANTITATIVE MOLECULAR RESPONSE AFTER DONOR LEUKOCYTE INFUSIONS FOR RELAPSED CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 237-237
OUTCOME OF DONOR LEUKOCYTE INFUSION (DLI) FOR RELAPSE AFTER BMT IS DEPENDENT ON THE INDICATION FOR TRANSPLANTATION AND CHIMERISM OF T-LYMPHOCYTES
Authors: SCHATTENBERG A SCHAAP N VANDEWIELVANKEMENADE E BAR B ROOVERS E PREIJERS F DEWITTE T
Citation: A. Schattenberg et al., OUTCOME OF DONOR LEUKOCYTE INFUSION (DLI) FOR RELAPSE AFTER BMT IS DEPENDENT ON THE INDICATION FOR TRANSPLANTATION AND CHIMERISM OF T-LYMPHOCYTES, Bone marrow transplantation, 21, 1998, pp. 241-241
CHIMERISM PATTERNS IN SUBPOPULATIONS OF PBMCS IN STABLE MIXED CHIMERAS CHIMERAS AFTER T-CELL DEPLETED BMT
Authors: SCHAAP N SCHATTENBERG A HILLEGERS M KNOPS R PENNINGS A DEWITTE T
Citation: N. Schaap et al., CHIMERISM PATTERNS IN SUBPOPULATIONS OF PBMCS IN STABLE MIXED CHIMERAS CHIMERAS AFTER T-CELL DEPLETED BMT, Bone marrow transplantation, 21, 1998, pp. 259-259
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA - AN EBMT HUTCHINSON,F. CRC/SFGM COLLABORATIVE STUDY/
Authors: GUARDIOLA P ANDERSON JE BANDINI B RUNDE V BACIGALUPO A CORNELISSEN JJ RUUTU T LJUNGMAN P VANBIEZEN A APPERLEY J DEWITTE T GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA - AN EBMT HUTCHINSON,F. CRC/SFGM COLLABORATIVE STUDY/, Bone marrow transplantation, 21, 1998, pp. 290-290
IDARUBICIN TO INTENSIFY THE CONDITIONING REGIMENS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: JERJIS S ROOVERS E MUUS P SCHAAP N DEWITTE T
Citation: S. Jerjis et al., IDARUBICIN TO INTENSIFY THE CONDITIONING REGIMENS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION, Bone marrow transplantation, 21, 1998, pp. 350-350
USE OF AN IMMUNOTOXIN-COCKTAIL (CD3-DGRTA) AND CD7-DGRTA) FOR THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST-DISEASE
Authors: VANOOSTERHOUT YVJM VANEMST L SCHATTENBERG A PREIJERS FWMB EVERS S TAX WJM SPITS H DEWITTE T
Citation: Yvjm. Vanoosterhout et al., USE OF AN IMMUNOTOXIN-COCKTAIL (CD3-DGRTA) AND CD7-DGRTA) FOR THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST-DISEASE, Bone marrow transplantation, 21, 1998, pp. 402-402
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT A GARCIACONDE J JULIUSSON G KUBEL M MANNA AT MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HG RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Bone marrow transplantation, 21, 1998, pp. 479-479
COST-ANALYSIS OF AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOPROLIFERATIVE MALIGNANCIES
Authors: JERJIS S CROOCKEWIT S ROOVERS E PREIJERS F SCHAAP N MUUS P DEWITTE T
Citation: S. Jerjis et al., COST-ANALYSIS OF AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOPROLIFERATIVE MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 685-685
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA, ON BEHALF OF THE MDS STUDY-GROUP OF THE EBMT CLWP AND THE EORTC-LCG
Authors: DEWITTE T VANBIEZEN A HERMANS J SUCIU S DARDENNE M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A MELONI G MAURI SB CARELLA A LAPORTE J DEMUYNCK H NIEDERWIESER D GRATWOHL A APPERLEY J
Citation: T. Dewitte et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA, ON BEHALF OF THE MDS STUDY-GROUP OF THE EBMT CLWP AND THE EORTC-LCG, Bone marrow transplantation, 21, 1998, pp. 750-750
TRANSPLANTATION OF BLOOD OR MARROW STEM-CELLS (BMT) FROM HLA-IDENTICAL SIBLINGS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR SECONDARY MYELOID-LEUKEMIA (SAML)
Authors: RUNDE V DEWITTE T VANBIEZEN A HERMANS J ARNOLD R LOCATELLI F GRATWOHL A APPERLEY J
Citation: V. Runde et al., TRANSPLANTATION OF BLOOD OR MARROW STEM-CELLS (BMT) FROM HLA-IDENTICAL SIBLINGS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR SECONDARY MYELOID-LEUKEMIA (SAML), Bone marrow transplantation, 21, 1998, pp. 751-751
BONE-MARROW TRANSPLANTATION (BMT) FOR CHILDREN WITH MYELODYSPLASTIC SYNDROME - AN EBMT REGISTRY ANALYSIS
Authors: LOCATELLI F GIORGIANI G VANBIEZEN A HERMANS J RUNDE V APPERLEY J DEWITTE T
Citation: F. Locatelli et al., BONE-MARROW TRANSPLANTATION (BMT) FOR CHILDREN WITH MYELODYSPLASTIC SYNDROME - AN EBMT REGISTRY ANALYSIS, Bone marrow transplantation, 21, 1998, pp. 752-752
RISK ASSESSMENT FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA BEFORE ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION
Authors: GRATWOHL A HERMANS J GOLDMAN JM ARCESE W CARRERAS E DEVERGIE A FRASSONI F GAHRTON G KOLB H NIEDERWIESER D RUUTU T VERNANT JP DEWITTE T APPERLEY J
Citation: A. Gratwohl et al., RISK ASSESSMENT FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA BEFORE ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION, Lancet, 352(9134), 1998, pp. 1087-1092
THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA
Authors: KEATING S DEWITTE T SUCIU S WILLEMZE R HAYAT M LABAR B RESEGOTTI L FERRINI PR CARONIA F DARDENNE M SOLBU G PETTI MC VEGNA ML MANDELLI F ZITTOUN RA
Citation: S. Keating et al., THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA, British Journal of Haematology, 102(5), 1998, pp. 1344-1353
QUANTITATION OF MINIMAL RESIDUAL DISEASE IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA PATIENTS USING REAL-TIME QUANTITATIVERT-PCR
Authors: MENSINK E VANDELOCHT A SCHATTENBERG A LINDERS E SCHAAP N VANKESSEL AG DEWITTE T
Citation: E. Mensink et al., QUANTITATION OF MINIMAL RESIDUAL DISEASE IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA PATIENTS USING REAL-TIME QUANTITATIVERT-PCR, British Journal of Haematology, 102(3), 1998, pp. 768-774
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>